Search results for "Virus Disease"

showing 10 items of 1907 documents

Effects of COVID-19 on Business Models in Romania and the Netherlands, A Digitalization Perspective

2020

Abstract The research objective is to study how Romanian and Dutch organizations’ business models have changed under COVID-19 conditions. The role of digitalization in adapting business models and business practices is studied. The theoretical background reviews literature about business models and their dimensions. Literature review investigated digitalization in Romanian and Dutch organizations. Research questions were: To what extent do Romanian and Dutch organizations use: • more digital methods in their offer to their clients now than before the crisis? • more digital methods in their business processes now than before the crisis? • more digital methods in communicating with their clie…

Value (ethics)Index (economics)HF5001-6182Social PsychologyCoronavirus disease 2019 (COVID-19)Business processEconomics Econometrics and Finance (miscellaneous)Business modeldigitalization0502 economics and businessBusinessbusiness modelsbusiness.industryRomanian05 social sciencesPerspective (graphical)business model innovationPublic relationslanguage.human_languageResilience (organizational)covid-19languageBusiness Management and Accounting (miscellaneous)050211 marketingbusiness050203 business & managementStudies in Business and Economics
researchProduct

The role of sense of community in harnessing the wisdom of crowds and creating collaborative knowledge during the COVID-19 pandemic

2021

Abstract This study investigates the role of sense of community in harnessing the wisdom of the crowd and creating collaborative knowledge during the COVID-19 pandemic. It also explores the impact of collaborative knowledge creation on the perceived value of social media crowdsourcing in such crises. PLS-SEM was used to analyze the data and test the research model. The results show that sense of community has a significant role in harnessing the wisdom of the crowd and creating collaborative knowledge. The results confirm a significant impact of sense of community, the wisdom of the crowd, and collaborative knowledge creation on the perceived value of social media crowdsourcing in respondin…

Value (ethics)MarketingCoronavirus disease 2019 (COVID-19)business.industry05 social sciencesSense of communityWisdom of the crowdSocial media crowdsourcingPublic relationsCrowdsourcingArticleTest (assessment)Collaborative knowledgePerceived valueWisdom of the crowd0502 economics and businessPandemic050211 marketingSocial mediaSociologybusiness050203 business & managementSense of communityJournal of Business Research
researchProduct

COVID-19 and the future of work and organisational psychology

2021

Orientation: The coronavirus disease 2019 (COVID-19) pandemic has caused a ‘coronafication’ of research and academia, including the instrumentalisation of academic research towards the demands of society and governments. Whilst an enormous number of special issues and articles are devoted on the topic, there are few fundamental reflections on how the current pandemic will affect science and work and organisational psychology in the long run.Research purpose: The current overview, written by a group of members of the Future of Work and Organisational Psychology (FOWOP) Movement, focuses on the central issues relating to work and organisational psychology that have emerged as a result of the …

Value (ethics)Social PsychologyCoronavirus disease 2019 (COVID-19)050109 social psychologyAffect (psychology)Argumentation theory0502 economics and businessRealmwork and organisational psychology0501 psychology and cognitive sciencestheoryApplied PsychologyOriginal ResearchIndustrial psychology05 social sciencesCOVID-19Covid19/dk/atira/pure/core/keywords/uob_covid19Work (electrical)Pluralism (political theory)neglected perspectiveswork and organizational psychologyEngineering ethicsFoWOPIndustrial and organizational psychologyCovid-19coronaHF5548.7-5548.85050203 business & managementN200 Management studiesSA Journal of Industrial Psychology
researchProduct

A combined measles, mumps, rubella and varicella vaccine (Priorix-Tetra: immunogenicity and safety profile

2009

Abstract Priorix-Tetra ™ (GlaxoSmithKline Biologicals) is a combined measles, mumps, rubella and varicella (MMRV) vaccine. Eight studies involving more than 3000 children were reviewed. Compared with co-administration of MMR ( Priorix ™) and varicella ( Varilrix ™) vaccines, the MMRV vaccine showed: similar immunogenicity, with immunity shown up to 3 years post-vaccination; a higher rate of fever after the first dose; a slight increase in mild local reactions after the second dose. This MMRV vaccine can be used either as a two-dose vaccine or as a second dose in children primed with separate MMR and/or varicella vaccines, offering a convenient way to introduce varicella vaccination into rou…

Varicella vaccineImmunization Secondarymedicine.vaccineAntibodies ViralRubellaMeaslesChickenpox VaccinemedicineHumansVaccines CombinedChildClinical Trials as TopicReactogenicityMMRV vaccineGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industryImmunogenicityPublic Health Environmental and Occupational HealthInfantvirus diseasesmedicine.diseaseVirologyVaccinationInfectious DiseasesImmunizationChild PreschoolMolecular MedicinebusinessMeasles-Mumps-Rubella Vaccine
researchProduct

MMR and MMRV vaccines.

2018

Measles, mumps, rubella and varicella are viral infections which can implicate seriously long-term sequelae of infected individuals or even the unborn child. Vaccines against the individual diseases have long been available. Global measles vaccination is estimated to have prevented more than 20million deaths during 2000-2015. During the same time period, measles incidence decreased from 146 to 36 cases per million populations. Today vaccinations against measles, mumps, rubella and varicella are now carried out mainly with combination vaccines. These are today known as immunogenic and safe. MMRV had similar immunogenicity and overall safety profiles to MMR administered with or without varice…

Varicella vaccineRubellaMeasles03 medical and health sciences0302 clinical medicineChickenpox030225 pediatricsmedicineHumans030212 general & internal medicineAdverse effectMumpsRubellaVaccinesGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industryImmunogenicityIncidence (epidemiology)VaccinationPublic Health Environmental and Occupational Healthvirus diseasesmedicine.diseaseVaccinationInfectious DiseasesImmunizationImmunologyMolecular MedicinebusinessMeaslesVaccine
researchProduct

Extrahepatic Morbidity and Mortality of Chronic Hepatitis C

2015

Chronic hepatitis C virus (HCV) infection is associated with several extra-hepatic manifestations. Patients with HCV may develop mixed cryoglobulinemia and its sequelae, ranging from cutaneous and visceral vasculitis to glomerulonephritis and B cell non-Hodgkin’s lymphoma. HCV-infected patients have increased rates of insulin resistance, diabetes and atherosclerosis, which may lead to increased cardiovascular morbidity and mortality. Neurologic manifestations of HCV infection include fatigue and cognitive impairment. The mechanisms causing the extra-hepatic effects of HCV infection are likely multifactorial and may include endocrine effects, HCV replication in extra-hepatic cells, or a heig…

VasculitisLymphomaGlomerulonephritis/epidemiology/virologyLymphoma/epidemiology/virologyHepatitis C virusAlpha interferonHepacivirusddc:616.07Cryoglobulinemia/epidemiology/virologymedicine.disease_causeAntiviral AgentsAntiviral Agents/administration & dosage/pharmacology/therapeutic useHepacivirus/drug effects/pathogenicityLiver diseasechemistry.chemical_compoundGlomerulonephritisDiabetes mellitusRibavirinmedicineHumansGlucose Metabolism Disorders/epidemiology/virologyInterferon alfaGlucose Metabolism Disordersddc:616Hepatologybusiness.industryHepatitis C Chronic/drug therapy/epidemiology/immunology/mortality/virologyRibavirinVasculitis/epidemiology/virologyGastroenterologyInterferon-alphavirus diseasesHepatitis C Chronicmedicine.diseaseCryoglobulinemiadigestive system diseasesCryoglobulinemiachemistryRibavirin/pharmacology/therapeutic useHCVImmunologyMorbiditybusinessVasculitisInterferon-alpha/pharmacology/therapeutic usemedicine.drugGastroenterology
researchProduct

Thrombotic complications of vaccination against SARS-CoV-2: what pharmacovigilance reports tell us – and what they don't

2021

In the present issue of the Journal [1], Smadja et al. present an analysis of global pharmacovigilance reports of thrombotic events following severe acute respiratory distress syndrome coronavirus (SARS-CoV)-2 vaccination. More specifically, the authors analysed the data entered into the World Health Organization (WHO) Global Database for Individual Case Safety Reports (VigiBase) between December 13, 2020 and March 16, 2021, covering, at that time, a population of almost 362 million vaccinated individuals across the world. The study focuses on three of the coronavirus disease (COVID)-19 vaccines available to date, namely the Pfizer-BioNtech (BNT162b2), Moderna (mRNA-1273), and OxfordAstraZe…

Venous ThrombosisPulmonary and Respiratory Medicine2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)SARS-CoV-2business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VaccinationCOVID-19ThrombosisVaccination03 medical and health sciencesEditorial0302 clinical medicine030228 respiratory systemPharmacovigilancemedicineHumans030212 general & internal medicineIntensive care medicinebusinessThrombotic complicationEuropean Respiratory Journal
researchProduct

Who can go back to work when the COVID-19 pandemic remits?

2020

AbstractThis paper seeks to determine which workers affected by lockdown measures can return to work when a government decides to apply lockdown exit strategies. This system, which we call Sequential Selective Multidimensional Decision (SSMD), involves deciding sequentially, by geographical areas, sectors of activity, age groups and immunity, which workers can return to work at a given time according to the epidemiological criteria of the country as well as that of a group of reference countries, used as a benchmark, that have suffered a lower level of lockdown de-escalation strategies. We apply SSMD to Spain, based on affiliation to the Social Security system prior to the COVID-19 pandemic…

Viral DiseasesEpidemiologyPathology and Laboratory MedicineGeographical locations0302 clinical medicineReturn to WorkMedical ConditionsPandemicMedicine and Health Sciences030212 general & internal medicineChildEpidemiology ; COVID-19 ; Virus testing ; Serotology ; Age groups ; Spain ; Death rates ; PandemicsVirus TestingAged 80 and overeducation.field_of_studyMultidisciplinaryExit strategyQRMiddle AgedEuropeInfectious DiseasesSerologyWork (electrical)Child PreschoolMedicineCoronavirus InfectionsResearch ArticleAdultCoronavirus disease 2019 (COVID-19)AdolescentDeath RatesScience030231 tropical medicinePopulationDecision MakingPneumonia ViralDecision tree03 medical and health sciencesBetacoronavirusYoung AdultPopulation MetricsDiagnostic MedicineBenchmark (surveying)HumansEuropean UnioneducationPandemicsAgedGovernmentActuarial sciencePopulation BiologySARS-CoV-2Decision TreesInfant NewbornCOVID-19InfantBiology and Life SciencesCovid 19Replication (computing)Social securitySpainAge GroupsPeople and PlacesPopulation GroupingsBusiness
researchProduct

PML nuclear body-residing proteins sequentially associate with HPV genome after infectious nuclear delivery.

2019

Subnuclear promyelocytic leukemia (PML) nuclear bodies (NBs) are targeted by many DNA viruses after nuclear delivery. PML protein is essential for formation of PML NBs. Sp100 and Small Ubiquitin-Like Modifier (SUMO) are also permanently residing within PML NBs. Often, large DNA viruses disassemble and reorganize PML NBs to counteract their intrinsic antiviral activity and support establishment of infection. However, human papillomavirus (HPV) requires PML protein to retain incoming viral DNA in the nucleus for subsequent efficient transcription. In contrast, Sp100 was identified as a restriction factor for HPV. These findings suggested that PML NBs are important regulators of early stages o…

Viral DiseasesPhysiologyvirusesIntranuclear Inclusion BodiesPromyelocytic Leukemia ProteinVirus ReplicationBiochemistryAutoantigensImmune PhysiologyMedicine and Health SciencesCell Cycle and Cell DivisionNuclear proteinBiology (General)PapillomaviridaeStaining0303 health sciencesViral GenomicsImmune System ProteinsChromosome Biology030302 biochemistry & molecular biologyCell StainingTotal Cell CountingNuclear Proteinsvirus diseasesAntigens NuclearGenomicsCell biologymedicine.anatomical_structureInfectious DiseasesCapsidCell ProcessesViral GenomeCellular Structures and OrganellesIntranuclear SpaceResearch ArticleHuman Papillomavirus InfectionQH301-705.5UrologyImmunologyCell Enumeration TechniquesSUMO-1 ProteinSexually Transmitted DiseasesMitosisMicrobial GenomicsGenome ViralBiologyResearch and Analysis MethodsMicrobiologyVirusAntibodies03 medical and health sciencesPromyelocytic leukemia proteinVirologyNuclear BodiesmedicineGeneticsHumansVesiclesMolecular BiologyMitosisTranscription factor030304 developmental biologyCell NucleusGenitourinary InfectionsTumor Suppressor ProteinsBiology and Life SciencesProteinsCell BiologyRC581-607Cell nucleusViral replicationSpecimen Preparation and Treatmentbiology.proteinParasitologyCapsid ProteinsImmunologic diseases. AllergyTranscription FactorsPLoS Pathogens
researchProduct

Modification of the immune response against hepatitis B virus by the human immunodeficiency virus.

1989

Hepatitis B virus and the human immunodeficiency virus are similarly transmitted. Individuals with preexisting HIV infection have a higher chance to become HBsAg carriers than do anti-HIV negative persons. Cytotoxic T cells with specificity for HBcAg, that are under the control of HBcAg-specific helper T cells, are responsible for liver injury. There is good evidence that HIV infection lowers inflammatory activity, is associated with milder liver histology, high levels of viral replication and low seroconversion rates. In addition interferon alpha therapy is less effective in anti-HIV positive subjects. The immune response against HBsAg is helper T-cell dependent and vaccination against hep…

Viral Hepatitis VaccinesHBsAgHepatitis B virusImmunologyAlpha interferonmedicine.disease_causeImmune systemRheumatologyHIV SeropositivitymedicineImmunology and AllergyHumansSeroconversionHepatitis ChronicHepatitis B virusImmunity Cellularbusiness.industryvirus diseasesHIVT-Lymphocytes Helper-InducerHepatitis Bmedicine.diseaseVirologyHBcAgImmunologyCarrier StateInterferon Type IbusinessViral loadT-Lymphocytes CytotoxicRheumatology international
researchProduct